중추신경계(CNS) 치료제 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 질환별, 약제 클래스별, 유통 채널별, 지역별 시장 예측(2025-2034년)

The central nervous system therapeutics market size is expected to reach USD 265.54 Billion by 2034, according to a new study by Polaris Market Research. The report "Central Nervous System Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Disease (Neurovascular Disease, CNS Trauma, Mental Health), By Drug Class, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Central Nervous System (CNS) therapeutics refers to treatments aimed at managing and alleviating disorders affecting the brain, spinal cord, and nerves, such as depression, epilepsy, Parkinson's disease, and Alzheimer's. These therapies include medications, biologics, and emerging digital and precision medicine approaches designed to improve neurological function and quality of life.

An aging population is one of the strongest drivers of the CNS therapeutics market. People become more prone to neurological and mental health conditions like Alzheimer's, Parkinson's, and dementia as people age. These age-related disorders are chronic and progressive, requiring long-term medical attention and treatment. The rise in the elderly population globally in region such as North America, Europe, and parts of Asia is putting pressure on healthcare systems to provide better and more efficient CNS care. Older adults are also more likely to seek medical help and adhere to treatment plans, driving consistent demand for CNS drugs and therapies. In response, pharmaceutical companies are focusing their research efforts on neurodegenerative conditions and age-related cognitive decline. Governments are further increasing funding for elderly healthcare programs, including those targeting CNS disorders. The need for effective, accessible, and safe CNS therapeutics rise as the global senior population continues to grow, thereby driving the growth.

The post-COVID-19 landscape has redefined healthcare priorities, placing greater emphasis on mental well-being and neurological care. The pandemic not only highlighted the vulnerabilities in accessing CNS treatments during health crises but also increased demand for digital therapeutics, remote care models, and innovative approaches to managing chronic neurological conditions. Governments and private organizations are also investing more into CNS research, driven by the growing burden of neurodegenerative and psychiatric illnesses, thereby driving the growth.

Central Nervous System Therapeutics Market Report Highlights

The mental health segment accounted for 26.15% share during the forecast period driven by a global rise in psychiatric conditions such as depression, anxiety, bipolar disorder, and schizophrenia.

The hospital pharmacy segment accounted USD 55.43 billion revenue in 2024 as many CNS treatments, especially for severe mental health or neurovascular conditions, are administered or initiated in hospital settings under close medical supervision.

North America central nervous system therapeutics market accounted for 40.24% global market share in 2024 driven by advanced healthcare infrastructure, high healthcare spending, and widespread awareness of neurological and mental health conditions.

The Asia Pacific central nervous system therapeutics market recorded USD 25.12 billion revenue in 2024, due to its large population, rising healthcare investment, and increasing awareness of neurological disorders.

The global key market players are AstraZeneca plc; Biogen Inc.; Eli Lilly and Company; Johnson & Johnson; Merck & Co., Inc.; Neuraxpharm; Novartis AG; Otsuka Pharmaceutical Co., Ltd; Pfizer Inc.; Takeda Pharma Company Ltd; Teva Pharmaceutical Industries Ltd.

Polaris market research has segmented the central nervous system therapeutics market report based on Disease, drug class, distribution channel, and region:

By Disease (Revenue - USD Billion, 2020-2034)

Neurovascular Diseases

CNS Trauma

Mental Health

Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Multiple Sclerosis

Huntington's Disease

Amyotrophic Lateral Sclerosis

Others

Infectious Diseases

CNS Cancer

Others

By Drug Class (Revenue - USD Billion, 2020-2034)

Anesthetics

Anticonvulsants

Antiemetic

CNS Stimulants

Pain Relievers

Others

By Distribution Channel (Revenue - USD Billion, 2020-2034)

Hospital Pharmacy

Retail Pharmacy

Other

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of APAC

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of MEA

Table of Contents

1. Global Central Nervous System Therapeutics Market-Report Overview

• 1.1. Scope of the report
• 1.2. Market Segment Analysis
• 1.3. Regulatory Scenario by Region/Country
• 1.4. Market Investment Scenario Strategic
• 1.5. Market Analysis by Disease (USD Million)
  • 1.5.1 Global Central Nervous System Therapeutics Market Share by Disease (2025-2034)
  • 1.5.2 Neurovascular Diseases
  • 1.5.3 CNS Trauma
  • 1.5.4 Mental Health
  • 1.5.5 Neurodegenerative Diseases
    • 1.5.5.1 Alzheimer's Disease
    • 1.5.5.2 Parkinson's Disease
    • 1.5.5.3 Multiple Sclerosis
    • 1.5.5.4 Huntington's Disease
    • 1.5.5.5 Amyotrophic Lateral Sclerosis
    • 1.5.5.6 Others
  • 1.5.6 Infectious Diseases
  • 1.5.7 CNS Cancer
  • 1.5.8 Others
• 1.6. Global Central Nervous System Therapeutics Market Share by Disease in 2025 & 2034
• 1.7. Market Analysis by Drug Class (USD Million)
  • 1.7.1 Global Central Nervous System Therapeutics Market Share by Drug Class (2025-2034)
  • 1.7.2 Anesthetics
  • 1.7.3 Anticonvulsants
  • 1.7.4 Antiemetic
  • 1.7.5 CNS Stimulants
  • 1.7.6 Pain Relievers
  • 1.7.7 Others
• 1.8. Global Central Nervous System Therapeutics Market Share by Drug Class in 2025 & 2034
• 1.9. Market Analysis by Distribution Channel (USD Million)
  • 1.9.1 Global Central Nervous System Therapeutics Market Share by Distribution Channel (2025-2034)
  • 1.9.2 Hospital Pharmacies
  • 1.9.3 Retail Pharmacies
  • 1.9.4 Others
• 1.10. Global Central Nervous System Therapeutics Market Share by Distribution Channel in 2025 & 2034

2. driver restraint challenge and opportunities of Central Nervous System Therapeutics Market

• 2.1. Driver, Restraint, Challenge and Opportunities Analysis
  • 2.1.1 Market Driver Analysis
  • 2.1.2 Market Restraint Analysis
  • 2.1.3 Market Opportunity
  • 2.1.4 Market Challenges

3. Global Growth Trends

• 3.1. Industry Trends
  • 3.1.1 SWOT Analysis
    • 3.1.1.1 Strengths
    • 3.1.1.2 Weaknesses
    • 3.1.1.3 Opportunities
    • 3.1.1.4 Threats
  • 3.1.2 PESTEL Analysis
    • 3.1.2.1 Political Landscape
    • 3.1.2.2 Economic Landscape
    • 3.1.2.3 Social Landscape
    • 3.1.2.4 Technological Landscape
    • 3.1.2.5 Environmental Landscape
    • 3.1.2.6 Legal Landscape
  • 3.1.3 Porter's Five Forces Analysis
    • 3.1.3.1 Bargaining Power of Suppliers
    • 3.1.3.2 Bargaining Power of Buyers
    • 3.1.3.3 Threat of Substitute
    • 3.1.3.4 Threat of New Entrant
    • 3.1.3.5 Competitive Rivalry
• 3.2. Potential Market and Growth Potential Analysis

4. Covid-19 Impact

• 4.1. Covid-19 Impact
• 4.2. COVID V, U, W and L Analysis
  • 4.2.1 COVID V Analysis
  • 4.2.2 COVID U Analysis
  • 4.2.3 COVID L Analysis
  • 4.2.4 COVID W Analysis

5. Companies Analysis

• 5.1. Global Central Nervous System Therapeutics Market, Sales Area, Product Type
• 5.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Central Nervous System Therapeutics Market
• 5.3. Companies List

6. Exceutive Summary

7. Global Central Nervous System Therapeutics Market Forecast, 2021-2034, (USD Million)

• 7.1. Global Central Nervous System Therapeutics Market

8. Global Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 8.1. Global Central Nervous System Therapeutics Market by Disease (2021-2027)
• 8.2. Global Central Nervous System Therapeutics Market by Disease (2028-2034)

9. Global Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2034), (USD Million)

• 9.1. Global Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 9.2. Global Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

10. Global Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 10.1. Global Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 10.2. Global Central Nervous System Therapeutics Market by Drug Class (2028-2034)

11. Global Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 11.1. Global Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 11.2. Global Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

12. Global Central Nervous System Therapeutics Market by REGION (2021-2034), (USD Million)

• 12.1. Global Central Nervous System Therapeutics Market by Region (2021-2027)
• 12.2. Global Central Nervous System Therapeutics Market by Region (2028-2034)

13. North America Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

• 13.1. North America Central Nervous System Therapeutics Market by Country (2021-2027)
• 13.2. North America Central Nervous System Therapeutics Market by Country (2028-2034)

14. North America Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 14.1. North America Central Nervous System Therapeutics Market by Disease (2021-2027)
• 14.2. North America Central Nervous System Therapeutics Market by Disease (2028-2034)
• 14.3. North America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 14.4. North America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

15. North America Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 15.1. North America Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 15.2. North America Central Nervous System Therapeutics Market by Drug Class (2028-2034)

16. North America Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 16.1. North America Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 16.2. North America Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

17. United States Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 17.1. United States Central Nervous System Therapeutics Market by Disease (2021-2027)
• 17.2. United States Central Nervous System Therapeutics Market by Disease (2028-2034)
• 17.3. United States Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 17.4. United States Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

18. United States Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 18.1. United States Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 18.2. United States Central Nervous System Therapeutics Market by Drug Class (2028-2034)

19. United States Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 19.1. United States Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 19.2. United States Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

20. Canada Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 20.1. Canada Central Nervous System Therapeutics Market by Disease (2021-2027)
• 20.2. Canada Central Nervous System Therapeutics Market by Disease (2028-2034)
• 20.3. Canada Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 20.4. Canada Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

21. Canada Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 21.1. Canada Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 21.2. Canada Central Nervous System Therapeutics Market by Drug Class (2028-2034)

22. Canada Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 22.1. Canada Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 22.2. Canada Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

23. Europe Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

• 23.1. Europe Central Nervous System Therapeutics Market by Country (2021-2027)
• 23.2. Europe Central Nervous System Therapeutics Market by Country (2028-2034)

24. Europe Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 24.1. Europe Central Nervous System Therapeutics Market by Disease (2021-2027)
• 24.2. Europe Central Nervous System Therapeutics Market by Disease (2028-2034)
• 24.3. Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 24.4. Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

25. Europe Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 25.1. Europe Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 25.2. Europe Central Nervous System Therapeutics Market by Drug Class (2028-2034)

26. Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 26.1. Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 26.2. Europe Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

27. United Kingdom Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 27.1. United Kingdom Central Nervous System Therapeutics Market by Disease (2021-2027)
• 27.2. United Kingdom Central Nervous System Therapeutics Market by Disease (2028-2034)
• 27.3. United Kingdom Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 27.4. United Kingdom Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

28. United Kingdom Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 28.1. United Kingdom Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 28.2. United Kingdom Central Nervous System Therapeutics Market by Drug Class (2028-2034)

29. United Kingdom Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 29.1. United Kingdom Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 29.2. United Kingdom Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

30. Germany Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 30.1. Germany Central Nervous System Therapeutics Market by Disease (2021-2027)
• 30.2. Germany Central Nervous System Therapeutics Market by Disease (2028-2034)
• 30.3. Germany Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 30.4. Germany Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

31. Germany Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 31.1. Germany Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 31.2. Germany Central Nervous System Therapeutics Market by Drug Class (2028-2034)

32. Germany Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 32.1. Germany Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 32.2. Germany Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

33. France Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 33.1. France Central Nervous System Therapeutics Market by Disease (2021-2027)
• 33.2. France Central Nervous System Therapeutics Market by Disease (2028-2034)
• 33.3. France Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 33.4. France Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

34. France Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 34.1. France Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 34.2. France Central Nervous System Therapeutics Market by Drug Class (2028-2034)

35. France Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 35.1. France Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 35.2. France Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

36. Spain Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 36.1. Spain Central Nervous System Therapeutics Market by Disease (2021-2027)
• 36.2. Spain Central Nervous System Therapeutics Market by Disease (2028-2034)
• 36.3. Spain Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 36.4. Spain Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

37. Spain Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 37.1. Spain Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 37.2. Spain Central Nervous System Therapeutics Market by Drug Class (2028-2034)

38. Spain Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 38.1. Spain Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 38.2. Spain Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

39. Italy Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 39.1. Italy Central Nervous System Therapeutics Market by Disease (2021-2027)
• 39.2. Italy Central Nervous System Therapeutics Market by Disease (2028-2034)
• 39.3. Italy Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 39.4. Italy Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

40. Italy Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 40.1. Italy Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 40.2. Italy Central Nervous System Therapeutics Market by Drug Class (2028-2034)

41. Italy Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 41.1. Italy Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 41.2. Italy Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

42. Netherlands Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 42.1. Netherlands Central Nervous System Therapeutics Market by Disease (2021-2027)
• 42.2. Netherlands Central Nervous System Therapeutics Market by Disease (2028-2034)
• 42.3. Netherlands Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 42.4. Netherlands Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

43. Netherlands Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 43.1. Netherlands Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 43.2. Netherlands Central Nervous System Therapeutics Market by Drug Class (2028-2034)

44. Netherlands Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 44.1. Netherlands Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 44.2. Netherlands Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

45. Russia Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 45.1. Russia Central Nervous System Therapeutics Market by Disease (2021-2027)
• 45.2. Russia Central Nervous System Therapeutics Market by Disease (2028-2034)
• 45.3. Russia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 45.4. Russia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

46. Russia Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 46.1. Russia Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 46.2. Russia Central Nervous System Therapeutics Market by Drug Class (2028-2034)

47. Russia Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 47.1. Russia Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 47.2. Russia Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

48. Rest of Europe Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 48.1. Rest of Europe Central Nervous System Therapeutics Market by Disease (2021-2027)
• 48.2. Rest of Europe Central Nervous System Therapeutics Market by Disease (2028-2034)
• 48.3. Rest of Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 48.4. Rest of Europe Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

49. Rest of Europe Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 49.1. Rest of Europe Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 49.2. Rest of Europe Central Nervous System Therapeutics Market by Drug Class (2028-2034)

50. Rest of Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 50.1. Rest of Europe Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 50.2. Rest of Europe Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

51. Asia Pacific Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

• 51.1. Asia Pacific Central Nervous System Therapeutics Market by Country (2021-2027)
• 51.2. Asia Pacific Central Nervous System Therapeutics Market by Country (2028-2034)

52. Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 52.1. Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2027)
• 52.2. Asia Pacific Central Nervous System Therapeutics Market by Disease (2028-2034)
• 52.3. Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 52.4. Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

53. Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 53.1. Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 53.2. Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2028-2034)

54. Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 54.1. Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 54.2. Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

55. China Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 55.1. China Central Nervous System Therapeutics Market by Disease (2021-2027)
• 55.2. China Central Nervous System Therapeutics Market by Disease (2028-2034)
• 55.3. China Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 55.4. China Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

56. China Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 56.1. China Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 56.2. China Central Nervous System Therapeutics Market by Drug Class (2028-2034)

57. China Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 57.1. China Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 57.2. China Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

58. India Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 58.1. India Central Nervous System Therapeutics Market by Disease (2021-2027)
• 58.2. India Central Nervous System Therapeutics Market by Disease (2028-2034)
• 58.3. India Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 58.4. India Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

59. India Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 59.1. India Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 59.2. India Central Nervous System Therapeutics Market by Drug Class (2028-2034)

60. India Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 60.1. India Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 60.2. India Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

61. Japan Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 61.1. Japan Central Nervous System Therapeutics Market by Disease (2021-2027)
• 61.2. Japan Central Nervous System Therapeutics Market by Disease (2028-2034)
• 61.3. Japan Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 61.4. Japan Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

62. Japan Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 62.1. Japan Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 62.2. Japan Central Nervous System Therapeutics Market by Drug Class (2028-2034)

63. Japan Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 63.1. Japan Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 63.2. Japan Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

64. South Korea Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 64.1. South Korea Central Nervous System Therapeutics Market by Disease (2021-2027)
• 64.2. South Korea Central Nervous System Therapeutics Market by Disease (2028-2034)
• 64.3. South Korea Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 64.4. South Korea Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

65. South Korea Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 65.1. South Korea Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 65.2. South Korea Central Nervous System Therapeutics Market by Drug Class (2028-2034)

66. South Korea Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 66.1. South Korea Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 66.2. South Korea Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

67. Indonesia Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 67.1. Indonesia Central Nervous System Therapeutics Market by Disease (2021-2027)
• 67.2. Indonesia Central Nervous System Therapeutics Market by Disease (2028-2034)
• 67.3. Indonesia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 67.4. Indonesia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

68. Indonesia Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 68.1. Indonesia Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 68.2. Indonesia Central Nervous System Therapeutics Market by Drug Class (2028-2034)

69. Indonesia Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 69.1. Indonesia Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 69.2. Indonesia Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

70. Malaysia Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 70.1. Malaysia Central Nervous System Therapeutics Market by Disease (2021-2027)
• 70.2. Malaysia Central Nervous System Therapeutics Market by Disease (2028-2034)
• 70.3. Malaysia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 70.4. Malaysia Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

71. Malaysia Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 71.1. Malaysia Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 71.2. Malaysia Central Nervous System Therapeutics Market by Drug Class (2028-2034)

72. Malaysia Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 72.1. Malaysia Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 72.2. Malaysia Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

73. Rest of Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 73.1. Rest of Asia Pacific Central Nervous System Therapeutics Market by Disease (2021-2027)
• 73.2. Rest of Asia Pacific Central Nervous System Therapeutics Market by Disease (2028-2034)
• 73.3. Rest of Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 73.4. Rest of Asia Pacific Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

74. Rest of Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 74.1. Rest of Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 74.2. Rest of Asia Pacific Central Nervous System Therapeutics Market by Drug Class (2028-2034)

75. Rest of Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 75.1. Rest of Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 75.2. Rest of Asia Pacific Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

76. Latin America Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

• 76.1. Latin America Central Nervous System Therapeutics Market by Country (2021-2027)
• 76.2. Latin America Central Nervous System Therapeutics Market by Country (2028-2034)

77. Latin America Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 77.1. Latin America Central Nervous System Therapeutics Market by Disease (2021-2027)
• 77.2. Latin America Central Nervous System Therapeutics Market by Disease (2028-2034)
• 77.3. Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 77.4. Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

78. Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 78.1. Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 78.2. Latin America Central Nervous System Therapeutics Market by Drug Class (2028-2034)

79. Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 79.1. Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 79.2. Latin America Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

80. Brazil Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 80.1. Brazil Central Nervous System Therapeutics Market by Disease (2021-2027)
• 80.2. Brazil Central Nervous System Therapeutics Market by Disease (2028-2034)
• 80.3. Brazil Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 80.4. Brazil Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

81. Brazil Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 81.1. Brazil Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 81.2. Brazil Central Nervous System Therapeutics Market by Drug Class (2028-2034)

82. Brazil Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 82.1. Brazil Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 82.2. Brazil Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

83. Argentina Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 83.1. Argentina Central Nervous System Therapeutics Market by Disease (2021-2027)
• 83.2. Argentina Central Nervous System Therapeutics Market by Disease (2028-2034)
• 83.3. Argentina Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 83.4. Argentina Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

84. Argentina Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 84.1. Argentina Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 84.2. Argentina Central Nervous System Therapeutics Market by Drug Class (2028-2034)

85. Argentina Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 85.1. Argentina Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 85.2. Argentina Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

86. Mexico Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 86.1. Mexico Central Nervous System Therapeutics Market by Disease (2021-2027)
• 86.2. Mexico Central Nervous System Therapeutics Market by Disease (2028-2034)
• 86.3. Mexico Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 86.4. Mexico Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

87. Mexico Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 87.1. Mexico Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 87.2. Mexico Central Nervous System Therapeutics Market by Drug Class (2028-2034)

88. Mexico Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 88.1. Mexico Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 88.2. Mexico Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

89. Rest of Latin America Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 89.1. Rest of Latin America Central Nervous System Therapeutics Market by Disease (2021-2027)
• 89.2. Rest of Latin America Central Nervous System Therapeutics Market by Disease (2028-2034)
• 89.3. Rest of Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2021-2027)
• 89.4. Rest of Latin America Central Nervous System Therapeutics Market by Neurodegenerative Diseases (2028-2034)

90. Rest of Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2034), (USD Million)

• 90.1. Rest of Latin America Central Nervous System Therapeutics Market by Drug Class (2021-2027)
• 90.2. Rest of Latin America Central Nervous System Therapeutics Market by Drug Class (2028-2034)

91. Rest of Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2034), (USD Million)

• 91.1. Rest of Latin America Central Nervous System Therapeutics Market by Distribution Channel (2021-2027)
• 91.2. Rest of Latin America Central Nervous System Therapeutics Market by Distribution Channel (2028-2034)

92. Middle East & Africa Central Nervous System Therapeutics Market by Country (2021-2034), (USD Million)

• 92.1. Middle East & Africa Central Nervous System Therapeutics Market by Country (2021-2027)
• 92.2. Middle East & Africa Central Nervous System Therapeutics Market by Country (2028-2034)

93. Middle East & Africa Central Nervous System Therapeutics Market by Disease (2021-2034), (USD Million)

• 93.1. Middle East & Africa Central Nervous System Therapeutics Market by Disease (2021-2027)
• 93.2. Middle East & Africa Central Nervous System Therapeutics Market